W World (WWHC) Stock Price, News & Analysis

Company Overview

W World Corp., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat a range of metabolic and nervous system disorders. The company focuses on the disorders of the brain-gut axis, pain/inflammation, and autoimmune, as well as gout disorders. Its lead compounds under clinically development include Levotofisopam, a non-sedating agent for the treatment of Gout; and Dextofisopam, a non-serotonergic agent, which has completed Phase IIa and Phase IIb clinical trials for the treatment of irritable bowel syndrome. The company was founded in 1990 and is headquartered in North Las Vegas, Nevada.

Key Stats

• Today's Range: $0.80 to $0.80
• 50-Day Range: $0.80 to $0.80
• 52-Week Range: $0.80 to $0.80
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

WWHC Stock Analysis - Frequently Asked Questions

How have WWHC shares performed this year?

W World's stock was trading at $0.80 at the beginning of the year. Since then, WWHC stock has increased by 0.0% and is now trading at $0.80.

How do I buy shares of W World?

Shares of WWHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of W World own?

Based on aggregate information from My MarketBeat watchlists, some other companies that W World investors own include Applied Materials (AMAT), Taiwan Semiconductor Manufacturing (TSM), Tesla (TSLA), Skyworks Solutions (SWKS), QUALCOMM (QCOM), NVIDIA (NVDA) and Lam Research (LRCX).

Company Calendar

• Today: 7/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:WWHC
• CIK: N/A
• Web: www.pharmoscorp.com
• Phone: (415) 841-3570
• Fax: 732-452-9557
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 0.70